Trials / Completed
CompletedNCT00193388
Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer
Phase II Trial of Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- SCRI Development Innovations, LLC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this phase II trial, we will evaluate the weekly schedule of topotecan in the second-line treatment of patients with small cell lung cancer
Detailed description
Upon determination of eligibility, all patients will be receive: * Topotecan
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topotecan |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2004-12-01
- Completion
- 2007-02-01
- First posted
- 2005-09-19
- Last updated
- 2010-07-28
Source: ClinicalTrials.gov record NCT00193388. Inclusion in this directory is not an endorsement.